about
Identification of two novel activities of the Wnt signaling regulator Dickkopf 3 and characterization of its expression in the mouse retinaPR72, a novel regulator of Wnt signaling required for Naked cuticle functionStabilization of ATF5 by TAK1-Nemo-like kinase critically regulates the interleukin-1β-stimulated C/EBP signaling pathwayActivation and function of the MAPKs and their substrates, the MAPK-activated protein kinasesDazap2 modulates transcription driven by the Wnt effector TCF-4Wnt signalling in lung development and diseasesTGF-β signaling via TAK1 pathway: role in kidney fibrosisPathogenesis of colorectal carcinoma and therapeutic implications: the roles of the ubiquitin-proteasome system and Cox-2Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor contextWnt5a regulates distinct signalling pathways by binding to Frizzled2Wnt signalling in stem cells and cancerAssociation of nuclear-localized Nemo-like kinase with heat-shock protein 27 inhibits apoptosis in human breast cancer cells.Regulation of FOXO1 by TAK1-Nemo-like kinase pathwayPostgenomic technologies targeting the Wnt signaling network.Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cellsTGF-β-activated kinase 1 is crucial in podocyte differentiation and glomerular capillary formation.Phosphorylation of TCF proteins by homeodomain-interacting protein kinase 2.β-Catenin-related protein WRM-1 is a multifunctional regulatory subunit of the LIT-1 MAPK complex.Mixed lineage kinase 3 modulates β-catenin signaling in cancer cellsThe N- or C-terminal domains of DSH-2 can activate the C. elegans Wnt/beta-catenin asymmetry pathwayNemo-like kinase inhibits osteoblastogenesis by suppressing bone morphogenetic protein and WNT canonical signaling.HOTAIR is a therapeutic target in glioblastoma.Common variation in Nemo-like kinase is associated with risk of ovarian cancer.What does it take to make a heart?Parallels between global transcriptional programs of polarizing Caco-2 intestinal epithelial cells in vitro and gene expression programs in normal colon and colon cancerNLK phosphorylates Raptor to mediate stress-induced mTORC1 inhibition.TGF-β-activated kinase-1: New insights into the mechanism of TGF-β signaling and kidney disease.Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer.Nemo-like kinase regulates the expression of vascular endothelial growth factor (VEGF) in alveolar epithelial cellsDifferential inhibition of Wnt-3a by Sfrp-1, Sfrp-2, and Sfrp-3.Transforming growth factor-beta (TGF-beta1) activates TAK1 via TAB1-mediated autophosphorylation, independent of TGF-beta receptor kinase activity in mesangial cells.NLK-mediated phosphorylation of HDAC1 negatively regulates Wnt signaling.Wnt signaling through T-cell factor phosphorylation.Cross-Regulation Between Wnt and NF-κB Signaling Pathways.TAK1, more than just innate immunity.The way Wnt works: components and mechanism.Post-Translational Modifications of the TAK1-TAB Complex.Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.Systems biology approach identifies the kinase Csnk1a1 as a regulator of the DNA damage response in embryonic stem cells.TAB2 scaffolds TAK1 and NLK in repressing canonical Wnt signaling
P2860
Q21558550-56808AAE-C2FC-40D5-9E3A-195BCB483E7CQ24293468-0A2C0ED4-554C-4013-980D-093C236F3D49Q24310121-4A70AA93-85D5-422F-AF87-1C0438119D77Q24632768-0544D1E3-7C4A-4B7E-BDA2-2CC41E9CF81DQ24657713-38EBECEB-5389-4B99-98BB-EA4426570A49Q25256712-128B5BA8-B19C-4DEC-A0A0-396808CEDBB6Q26824337-F1F44FE1-E63B-4082-B641-791F577E8352Q28209990-3FBE113B-0344-48A3-8B87-73B401133AAEQ28510950-6091B8B8-CA7E-412D-9D83-BA9D0BDBFFF6Q28588878-AEF5776B-26BF-413C-9F7E-FE27B37CBC1CQ29547862-ACECE6D2-6713-448A-BA80-8449EEA008B8Q33590271-69841387-99A8-4CF4-B903-330DF01ACBB7Q33707056-2FAB2D8E-7A29-4226-9288-3F3249B7B478Q33838680-7740EE4B-D833-4356-B094-552A43007E7CQ34012237-CA62D4F2-C555-4166-BF2B-69669D5F4034Q34103389-D3FE60E5-1A45-4672-ABED-D974E09FC587Q34752073-96BC1C5B-62F8-4B1E-B6A0-0FF10C9C9B7AQ34985707-E9AC04DF-D84F-4538-B707-128F5D13C1AEQ35423826-0DB3F7DB-0EBB-450E-A4A7-E69B6044E3AEQ35536520-CA549C8E-E6FF-45A3-822E-F604847A6142Q35659209-F876C251-B20C-4DD3-8263-2A7D0611EF43Q35781595-E855B60D-E75C-4907-B059-FCE3994C4726Q35815383-A46D089B-84F6-44C7-8CBE-E2BB967F1F06Q36044408-4DB57300-C3EA-4976-BF9A-95E2B573A121Q36095701-474FFA25-49A5-4B21-8D6B-2644294A6B13Q36406372-EB6AB68E-E404-4107-B320-99ED5880C8C1Q36468657-AA3B9E47-A9EB-41C9-9716-0DB0E1400D69Q36570605-9F2D9C93-11EC-4CA6-B34B-7E97F4E052A2Q36755983-C0466E26-C16B-43C1-A97F-3D27F000D693Q36935598-A7288745-C522-4E19-AB71-FBD9E831D32CQ37372277-5938732B-8CE4-44D9-B680-75D4360EBE44Q37583269-FE17BEC9-2779-423D-A737-EDBC2BD2704BQ37878851-DD1654E5-53D0-49C6-ABE3-58258085DE0CQ37891671-36ACE6DD-4B48-4AC6-B68A-095744FD2CA4Q38040025-2969E70C-D0DD-4BD5-A1DF-700B4C635508Q38068918-72B2EC90-B4F6-4DB1-9445-2D58ED45921AQ39096576-1BB6A945-B19A-4957-94B2-F1C360ECA3C7Q39117288-5A4B18CC-1880-4D21-8C26-254DA61B9405Q39203761-5ED54293-4678-4520-B2B1-749894BA418DQ39733618-28FE1105-4F16-495E-ABAC-1CAB6DFFABA4
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Wnt activates the Tak1/Nemo-like kinase pathway
@ast
Wnt activates the Tak1/Nemo-like kinase pathway
@en
Wnt activates the Tak1/Nemo-like kinase pathway
@nl
type
label
Wnt activates the Tak1/Nemo-like kinase pathway
@ast
Wnt activates the Tak1/Nemo-like kinase pathway
@en
Wnt activates the Tak1/Nemo-like kinase pathway
@nl
prefLabel
Wnt activates the Tak1/Nemo-like kinase pathway
@ast
Wnt activates the Tak1/Nemo-like kinase pathway
@en
Wnt activates the Tak1/Nemo-like kinase pathway
@nl
P2093
P2860
P3181
P356
P1476
Wnt activates the Tak1/Nemo-like kinase pathway
@en
P2093
Annette Baas
Hans Clevers
Hendrik Korswagen
Jeroen Kuipers
Linda Smit
Marc van de Wetering
P2860
P304
P3181
P356
10.1074/JBC.M307801200
P407
P577
2004-04-23T00:00:00Z